BioNTech SE (NAS:BNTX)
$ 115.59 -1.61 (-1.37%) Market Cap: 27.71 Bil Enterprise Value: 9.82 Bil PE Ratio: 0 PB Ratio: 1.31 GF Score: 66/100

BioNTech SE at JPMorgan NAPA Valley Forum (Virtual) Transcript

Mar 31, 2021 / 02:00PM GMT
Release Date Price: $109.19 (+4.55%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good morning, everyone, and actually, good afternoon to you, Ryan. My name is Cory Kasimov, one of the senior biotech analysts at JPMorgan. And welcome to day 3 of our 10th Annual Napa Valley Biotech Forum. It is my pleasure to be here today hosting this discussion with BioNTech, one of the companies that's hopefully going to be a key reason why we're all gathered together in the actual Napa Valley next year.

So we have here with us Ryan Richardson, the Chief Strategy Officer and Managing Director from BioNTech. So Ryan, thank you very much for being here.

Before we get started with questions, let me just remind everybody, that you're able to contribute to this conversation using that little blue button in the portal to ask a question, and we'll work those into our conversation as we go forward.

So Ryan, thanks again. I look forward to this discussion with you today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot